Augmenix, INC.
Improving the outcomes of radiotherapy through the use of absorbable hydrogels.
Based in MA
AI Overview
With $61K in lobbying spend across 7 quarterly filings, Augmenix, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2019.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $24K |
| 2019 | $37K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Augmenix, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
Improving the outcomes of radiotherapy through the use of absorbable hydrogels.
Medicare coverage polices in regards to SpaceOAR hydrogel, which is used to prevent radiation exposure during prostate radiation therapy
Medicare coverage polices in regards to SpaceOAR hydrogel, which is used to prevent radiation exposure during prostate radiation therapy.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.